A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: A phase I/II study

Journal of Molecular Medicine

Volumn 80, Issue 9, 2002, Pages 610-614

  Winiarczyk, Stanislaw ^a   Gradski, Zbigniew ^a   Kosztolich, Barbara ^b   Gabler, Cornelia ^b   König, Gerhardt ^b   Renner, Matthias ^c   Saller, Robert M ^d   Prosl, Heinrich ^b   Salmons, Brian ^c   Günzburg, Walter H ^b   Hain, Johannes ^d  

^a UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c Austrianova Biotherapeutics   (Austria)

^d Bavarian Nordic GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOCHROME P450; ALKYLATING AGENT; CYTOCHROME P450 2B1; PRODRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER CHEMOTHERAPY; CELL ENCAPSULATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DOG; FEMALE; MEDICAL ASSESSMENT; NONHUMAN; TUMOR VOLUME; ANIMAL; CELL TRANSPLANTATION; DOG DISEASE; EXPERIMENTAL NEOPLASM; FOLLOW UP; GENE EXPRESSION; GENE THERAPY; GENETICS; HUMAN; INJECTION; METABOLISM; METHODOLOGY; MICROCAPSULE; MULTIMODALITY CANCER THERAPY; PILOT STUDY; TREATMENT OUTCOME; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CAPSULES; CELL TRANSPLANTATION; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTOCHROME P-450 CYP2B1; DOG DISEASES; DOGS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GENE THERAPY; HUMANS; INJECTIONS; MAMMARY NEOPLASMS, ANIMAL; PILOT PROJECTS; PRODRUGS; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 0036378984     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-002-0356-0     Document Type: Article

References (13)

1. Gordon A (1997) The increasing efficacy of breast cancer treatment. Clin Oncol (R Coll Radiol) 9:338-342
2. Genka S, Deutsch J, Stahle PL, Shetty UH, John V, Rapoport SI, Greig NH (1990) Brain and plasma pharmacokinetics and anti-cancer activities of cyclophosphamide and phosphoramide mustard in the rat. Cancer Chemother Pharmacol 27:1-7
3. Dautzenberg H, Schuldt U, Grasnick G, Karle P, Müller P, Löhr M, Pelegrin M, Piechaczyk M, Von Rombs K, Günzburg WH, Salmons B, Saller RM (1999) Development of cellulose sulphate based polyelectrolyte complex microcapsules for medical applications. Ann NY Acad Sci 875:46-63
4. Lohr JM, Hoffmeyer A, Krüger J-C, Freund M, Hain J, Holle A, Karle P, Knöfel WT, Liebe S, Müller P, Nizze H, Renner M, Saller RM, Wagner T, Hauenstein K, Günzburg WH, Salmons B (2001) Microencapsulated cell mediated therapy of inoperable pancreatic carcinoma. Lancet 357:1591-1592
5. Kammertöns T, Gelbmann W, Karle P, Saller R, Salmons B, Günzburg WH, Uckert W (2000) Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine. Cancer Gene Ther 7:629-636
6. Günzburg WH, Karle P, Renz R, Salmons B, Renner M (1999) Characterisation of a human cell clone expressing cytochrome P450 for safe use in human somatic cell therapy. Ann NY Acad Sci 30:880:326-336
7. Perez Alenza MD, Pena L, Del Castillo N, Nieto AI (2000) Factors influencing the incidence and prognosis of canine mammary tumours. J Small Anim Pract 41:287-291
8. Brodey RS, Goldschmidt MH, Roszel JR (1983) Canine mammary gland neoplasms. J Am Anim Hosp Assoc 19:61-90
9. Simon D, Goronzy P, Stephan I, Meyer-Lindenberg A, Aufderheider M, Nolte I (1996) Mammatumoren beim Hund: Untersuchung zu Vorkommen und Verlauf der Erkrankung. Praktische Tierarzt 9:771-782
10. Kuntze A, Kuntze O (1993) Zur Chirurgie der Mammatumoren bei Hund und Katze. Mh Vet Med 48:467-472
11. Karayannopoulou M, Kaldrymidou E, Constantinidis TC, Dessiris A (2001) Adjuvant post-operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 48:85-96
12. Löhr M, Müller P, Karle P, Stange J, Mitzner S, Jesenowski R, Nizze H, Nebe B, Liebe S, Salmons B, Günzburg WH (1998) Targeted chemotherapy by encapsulating cells engineered to deliver CYP2B1, an ifosfamide activating cytochrome P450 gene. Gene Ther 5:1070-1078
13. Löhr JM, Bago ZT, Bergmeister H, Ceijka M, Freund M, Gelbmann W, Günzburg, WH, Hain J, Hauenstein K, Henniger W, Hoffmeyer A, Karle P, Kröger J-C, Liebe S, Losert U, Probst A, Renner M, Renz R, Saller R, Salmons B, Schuh M, Wagner T, Walter I (1999) Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced stage carcinoma: phase I/II study. J Mol Med 77:393-398